Protein Crystallization and Crystallography Market is forecasted to value over USD 2 billion by 2028 end and register a CAGR of 8.5% from the forecast period 2021-2028.

The report on Protein Crystallization and Crystallography Market by Future Market Analytics consists of the market trends like the regularization of the usage of renewable energy resources, digitization of the chemical industry, etc. that have the potential of transforming the market growth. Furthermore, the report includes insightful data points on the overall Protein Crystallization and Crystallography Market share, the impact of the market on the tech and commercial industry for the real-time process refinement and business expansion, revenue management, etc. The report also includes the competitive landscape ranging from key market players to new entrants and their SWOT analysis along with the geographical analysis of regions such as North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.

With the assistance of the latest market research methodologies, the market analysts at Future Market Analytics have estimated that the Protein Crystallization and Crystallography Market is anticipated to attain significant augmentation within the forecasted timeframe. The report includes insights regarding the Protein Crystallization and Crystallography Market size and the current market valuation coupled with detailed information on the market segmentation and the available growth opportunities in the business vertical.

Major players included in the Protein Crystallization and Crystallography Market:

  • Rigaku Corporation
  • Hampton Research
  • Jena Bioscience GmbH
  • Bruker Corporation
  • Molecular Dimensions Ltd
  • Formulatrix, Inc
  • MiTeGen LLC
  • Biogenuix
  • Arinax Scientific Instrumentation
  • HiMedia Laboratories
  • Agilent Technologies, Inc.
  • Anton Paar GmbH
  • Danaher
  • General Electric
  • MiTeGen, LLC
  • Thermo Fisher Scientific Inc.
  • Corning Incorporated
  • Tecan Group
  • Charles River Laboratories
  • Creative Biostructure

(Note: The list of the major players will be updated with the latest market scenario and trends)

Protein Crystallization and Crystallography Market Segmentation:
By Technology

  • X-ray Crystallography
  • Nuclear Magnetic Resonance (NMR)
  • Cryo-Electron Microscopy
  • Others (SAXS)

By Product & Service

  • Consumables
    • Microplates
      • 96 well-plates
      • 48-well plates
      • 24-well plates
    • Crystal Mounts and Loops
    • Reagents Kits/Screens
    • Other Consumables
  • Instruments
    • Liquid Handling Instruments
      • Automated
      • Manual
    • Crystal Imaging Instruments
  • Software & Services

By End Use Industry

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Government Institutes
  • Academic Institutes

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Protein Crystallization and Crystallography Market Competitive Analysis:

  • Tier-1 Players
  • Tier-2 Players
  • Emerging Players
  • New Entrants

Future Market Analytics Focus Points:

  • SWOT Analysis
  • Key Market Trends
  • Key Data -Points Affecting Market Growth
  • Revenue and Forecast Analysis
  • Growth Opportunities For New Entrants and Emerging Players
  • Key Player and Market Growth Matrix

Objectives of the Study:

  • To provide a comprehensive analysis on the Protein Crystallization and Crystallography Market by technology, by product & service, by end use industry and by region
  • To cater extensive insights on factors influencing the market growth (drivers, restraints, industry-specific restraints, business expansion opportunities)
  • To anticipate and analyse the market size expansion in key regions- North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- strategic alliances and mergers, technological advancements and product launches, revenue and financial analysis of key market players

 
In case of any requirements or changes to the current table of content please contact us at:enquiry@futuremarketanalytics.com

Description

1. Market Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Market Scope
         1.3.1 Years Considered for the Study
         1.3.2 Market Covered
    1.4. Currency
    1.5. Limitations
    1.6. Stakeholders

2. Research Methodology
    2.1. Research Data
         2.1.1. Secondary Data
                2.1.1.1. Key Data from Secondary Sources
         2.1.2. Primary Data
                2.1.2.1. Key Data from Primary Sources
    2.2. Market Size Estimation
    2.3. Market Breakdown and Data Triangulation
    2.4. Assumptions for the Study

3. Executive Summary
    3.1. Market Outlook
    3.2. Segment Outlook
    3.3. Competitive Insights

4. Market Variables, Trends & Scope
    4.1. Market Lineage Outlook
    4.2. Penetration and Growth Prospect Mapping
    4.3. Industry Value Chain Analysis
    4.4. Cost Analysis Breakdown
    4.5. Technology Overview
    4.6. Regulatory Framework on Country Level
         4.6.1. Reimbursement Framework
         4.6.2. Standards and Compliances

5. Market Overview
    5.1. Market Dynamics
         5.1.1. Market Driver Analysis
         5.1.2. Market Restraint Analysis
         5.1.3. Industry Challenges

6. Market Analysis Tools
    6.1. Industry Analysis – Porter’s
         6.1.1. Supplier Power
         6.1.2. Buyer Power
         6.1.3. Substitution Threat
         6.1.4. Threat from new entrants
         6.1.5. Competitive Rivalry
    6.2. Pestel Analysis
         6.2.1. Political Landscape
         6.2.2. Environmental Landscape
         6.2.3. Social landscape
         6.2.4. Technology landscape
         6.2.5. Legal Landscape

7. Protein Crystallization and Crystallography Market, By Technology Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    7.1. X-ray Crystallography
    7.2. Nuclear Magnetic Resonance (NMR)
    7.3. Cryo-Electron Microscopy
    7.4. Others (SAXS)

8. Protein Crystallization and Crystallography Market, By Product & Services Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    8.1 Consumables
         8.1.1. Microplates
                8.1.1.1. 96 well-plates
                8.1.1.2. 48-well plates
                8.1.1.3. 24-well plates
         8.1.2. Crystal Mounts and Loops
         8.1.3. Reagents Kits/Screens
         8.1.4. Other Consumables
    8.2 Instruments
         8.2.1. Liquid Handling Instruments
                8.2.1.1. Automated
                8.2.1.2. Manual
         8.2.2. Crystal Imaging Instruments
         8.2.3. Others
    8.3. Software & Services

9. Protein Crystallization and Crystallography Market, By End Use Industry Historical Analysis 2016-2020 and Forecast 2021-2028 (USD million)
    9.1. Pharmaceutical Companies
    9.2. Biotechnology Companies
    9.3. Government Institutes
    9.4.. Academic Institutes

10. North America Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         10.2.1. U.S.
         10.2.2. Canada
         10.2.3. Mexico
         10.2.4. Rest of North America
    10.3. Market Size (USD Mn) Forecast for North America 2021-2028

11. Latin America Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    11.1. Introduction
    11.2. Regional Market Trends
    11.3. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         11.3.1. Brazil
         11.3.2. Venezuela
         11.3.3. Argentina
         11.3.4. Rest of Latin America
    11.4 Market Size (USD Mn) Forecast for Latin America 2021-2028

12. Europe Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         12.2.1. Germany
         12.2.2. U.K
         12.2.3. France
         12.2.4. Italy
         12.2.5. Switzerland
         12.2.6. Spain
         12.2.7. Russia
         12.2.8. Poland
         12.2.9. Rest of Europe
    12.3. Market Size (USD Mn) Forecast for Europe 2021-2028

13. Asia Pacific Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         13.2.1 Japan
         13.2.2 China
         13.2.3 Singapore
         13.2.4 Korea
         13.2.5 India
         13.2.6 Australia and New Zealand
         13.2.7 ASEAN
         13.2.8 Rest of Asia Pacific
    13.3. Market Size (USD Mn) Forecast for Asia Pacific 2021-2028

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2021-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Mn) Analysis By Country, 2016-2020
         14.2.1 UAE
         14.2.2 South Africa
         14.2.3 Egypt
         14.2.4 Saudi Arabia
         14.2.5 Rest of MEA
    14.3. Market Size (USD Mn) Forecast for MEA 2021-2028

15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    15.1. Rigaku Corporation
         15.1.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.1.2. Product Portfolio
         15.1.3. SWOT Analysis
         15.1.4. Financial Overview
         15.1.5. Strategic Overview
    15.2. Hampton Research
         15.2.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.2.2. Product Portfolio
         15.2.3. SWOT Analysis
         15.2.4. Financial Overview
         15.2.5. Strategic Overview
    15.3. Jena Bioscience GmbH
         15.3.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.3.2. Product Portfolio
         15.3.3. SWOT Analysis
         15.3.4. Financial Overview
         15.3.5. Strategic Overview
    15.4. Bruker Corporation
         15.4.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.4.2. Product Portfolio
         15.4.3. SWOT Analysis
         15.4.4. Financial Overview
         15.4.5. Strategic Overview
    15.5. Molecular Dimensions Ltd
         15.5.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.5.2. Product Portfolio
         15.5.3. SWOT Analysis
         15.5.4. Financial Overview
         15.5.5. Strategic Overview
    15.6. Formulatrix, Inc
         15.6.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.6.2. Product Portfolio
         15.6.3. SWOT Analysis
         15.6.4. Financial Overview
         15.6.5. Strategic Overview
    15.7. MiTeGen LLC
         15.7.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.7.2. Product Portfolio
         15.7.3. SWOT Analysis
         15.7.4. Financial Overview
         15.7.5. Strategic Overview
    15.8. Biogenuix
         15.8.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.8.2. Product Portfolio
         15.8.3. SWOT Analysis
         15.8.4. Financial Overview
         15.8.5. Strategic Overview
    15.9. Arinax Scientific Instrumentation
         15.9.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.9.2. Product Portfolio
         15.9.3. SWOT Analysis
         15.9.4. Financial Overview
         15.9.5. Strategic Overview
    15.10. HiMedia Laboratories
         15.10.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.10.2. Product Portfolio
         15.10.3. SWOT Analysis
         15.10.4. Financial Overview
         15.10.5. Strategic Overview
    15.11. Agilent Technologies, Inc.
         15.11.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.11.2. Product Portfolio
         15.11.3. SWOT Analysis
         15.11.4. Financial Overview
         15.11.5. Strategic Overview
    15.12. Anton Paar GmbH
         15.12.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.12.2. Product Portfolio
         15.12.3. SWOT Analysis
         15.12.4. Financial Overview
         15.12.5. Strategic Overview
    15.13. Danaher
         15.13.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.13.2. Product Portfolio
         15.13.3. SWOT Analysis
         15.13.4. Financial Overview
         15.13.5. Strategic Overview
    15.14. General Electric
         15.14.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.14.2. Product Portfolio
         15.14.3. SWOT Analysis
         15.14.4. Financial Overview
         15.14.5. Strategic Overview
    15.15. MiTeGen, LLC
         15.15.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.15.2. Product Portfolio
         15.15.3. SWOT Analysis
         15.15.4. Financial Overview
         15.15.5. Strategic Overview
    15.16. Thermo Fisher Scientific Inc.
         15.16.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.16.2. Product Portfolio
         15.16.3. SWOT Analysis
         15.16.4. Financial Overview
         15.16.5. Strategic Overview
    15.17. Corning Incorporated
         15.17.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.17.2. Product Portfolio
         15.17.3. SWOT Analysis
         15.17.4. Financial Overview
         15.17.5. Strategic Overview
    15.18. Tecan Group
         15.18.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.18.2. Product Portfolio
         15.18.3. SWOT Analysis
         15.18.4. Financial Overview
         15.18.5. Strategic Overview
    15.19. Charles River Laboratories
         15.19.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.19.2. Product Portfolio
         15.19.3. SWOT Analysis
         15.19.4. Financial Overview
         15.19.5. Strategic Overview
    15.20. Creative Biostructure
         15.20.1. Company Overview (HQ, Business Segments, Employee Strength)
         15.20.2. Product Portfolio
         15.20.3. SWOT Analysis
         15.20.4. Financial Overview
         15.20.5. Strategic Overview

16. Impact of COVID-19
    16.1. Positive influence on the industry
    16.2. The financial disruption of the sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the industry regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations

17. Competitive Intelligence and Competitive Matrix
    17.1. Competitive Intelligence
    17.2. Competitive Matrix

18. Major Deals and Strategic Alliances Analysis
    18.1. Joint ventures
    18.2. Mergers and acquisitions
    18.3. Licensing and partnerships
    18.4. Technology Collaborations
    18.5. Strategic Divestments
    18.6. Market Entry Strategies

19. Relevant Case Studies and Latest News Updates

20. Key Market Takeaway Points from the Market Analysts at Future Market Analytics